Affini-T Raises $175m For Bicoastal TCR Play Focused On KRAS-Mutated Solid Tumors

 
• By Joseph Haas
  
Affini-T cancer cell therapy
Affini-T plans to target KRAS mutations with TCR therapeutics • Source: Alamy

More from Financing

More from Business